Newsletter

Undervalued Stocks

Here are 4 of the worst red flags for stocks that you need to watch out for

Investors should always be on the look out for red flags for stocks. We're talking about subtle signs that may not appear to mean much in isolation, but could indicate that you have a bad company and you need to get out of it before you risk making a big loss on your investment. Here 4…

ByNick SundichMay 5, 2025

Appen shares have plunged 90% from their peak! Is there any end to the bloodbath in sight?

There are few ASX shares that have seen such a fall from grace as Appen shares since 2020. In those days, Appen was such a good stock, it was part of a quintet of stocks deemed the WAAAX stocks and claimed to have outperformed the American FAANG stocks. Moreover, it was capitalised at over $3bn. While…

ByNick SundichApril 2, 2025

6 Undervalued Lithium Stocks to Invest In

As the global push towards decarbonization accelerates, lithium has emerged as one of the most vital resources for a cleaner future. With its indispensable role in battery technology, especially for electric vehicles (EVs) and renewable energy storage, lithium demand is forecast to outstrip supply for years to come. Despite the recent price corrections and market…

ByUjjwal MaheshwariApril 1, 2025

Should you use your tax cut to invest in stocks? And how should you go about it?

Should you use your tax cut to invest in stocks? With another unexpected round of tax cuts starting from the middle of next year, unveiled in the federal budget earlier this week, this is a question facing many. This round isn't that large - only $536 a year and little over $10 a week by…

ByNick SundichMarch 27, 2025

It is only March, but there 6 ASX stocks have received takeover bids! What will happen to them?

6 ASX stocks that have received takeover bids already in 2025 Dropsuite (ASX:DSE) Unlike other bids which we will list, this offer will be going ahead with this company having signed a binding deal and recommending to shareholders to vote for the transaction. It was not a big premium, with the share price being a…

ByNick SundichMarch 17, 2025

Here are 2 great ASX Electric Vehicle Stocks to Buy Now!

The question of which ASX Electric Vehicle Stocks to Buy Now may not appear to be one worth asking at first glance. This is because there are no pureplay Electric Vehicle makers listed on the ASX. Investors wanting exposure to them will have to invest in overseas stock exchanges. There are also dozens of lithium…

ByNick SundichFebruary 27, 2025

oOh!media (ASX:OML): Talk of its demise has been greatly exaggerated!

See a massive billboard on an arterial road, and there is a good chance that oOh!media (ASX:OML) was behind it. It is great to have a dominant market position, but this has not prevented shares sliding over 25% in the past 12 months due to cost blowouts and a difficult position with the advertising market.…

ByNick SundichFebruary 6, 2025

Firstwave Cloud Technology (ASX:FCT): A changed company with a plethora of market opportunities

It seems the Tech Wreck is finally over as plenty of technology stocks have been rebounding, although Firstwave Cloud Technology (ASX:FCT) hasn't. One of the arguable reasons is that investors think the company has not changed from what it was a few years ago. The reality is that even though the company has the same…

ByNick SundichFebruary 5, 2025

3 emerging markets for stock investors to consider, and 3 to avoid!

Let's take a look at Emerging markets for stock investors in Australia to consider. Australians looking to offshore markets may consider the US and New Zealand first, with perhaps Western Europe thereafter. However, if investors expand their horizons to emerging markets, there's plenty of additional opportunity. Investors can buy these companies directly or can invest in…

ByNick SundichJanuary 6, 2025

Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!

Here are our 6 Best ASX Stocks for 2025! Opthea (ASX:OPT) Its been a long wait, but 2025 will finally be the year Opthea (ASX:OPT) investors receive Phase 3 results. Opthea is an optometry biotech developing Sozinibercept - a drug fighting wet AMD. Wet AMD is the leading cause of blindness, impacting 3.5m people annually…

ByNick SundichDecember 27, 2024